Pan, Edward <br/><br/>
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma.  [electronic resource] 

 -  Journal of neuro-oncology  12 2016 
 - 571-579 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1573-7373 
<br/><br/><label>Standard No.: </label>10.1007/s11060-016-2263-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Benzazepines--therapeutic use<br/>Bevacizumab--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Female<br/>Glioma--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Time Factors